Hormone Receptor–Positive, HER2-Negative Breast Cancer: Recent Advances and Best Practices

Lee Schwartzberg, MD, FACP, and Heather Greene, MSN, FNP, AOCNP®, reviewed optimal therapy for patients with hormone receptor–positive, HER2-negative breast cancer, as well as the management of adverse events associated with treatment.

Detalles Bibliográficos
Autores principales: Schwartzberg, Lee, Greene, Heather
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2020
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857322/
https://www.ncbi.nlm.nih.gov/pubmed/33598325
http://dx.doi.org/10.6004/jadpro.2020.11.3.12
_version_ 1783646425238732800
author Schwartzberg, Lee
Greene, Heather
author_facet Schwartzberg, Lee
Greene, Heather
author_sort Schwartzberg, Lee
collection PubMed
description Lee Schwartzberg, MD, FACP, and Heather Greene, MSN, FNP, AOCNP®, reviewed optimal therapy for patients with hormone receptor–positive, HER2-negative breast cancer, as well as the management of adverse events associated with treatment.
format Online
Article
Text
id pubmed-7857322
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-78573222021-02-16 Hormone Receptor–Positive, HER2-Negative Breast Cancer: Recent Advances and Best Practices Schwartzberg, Lee Greene, Heather J Adv Pract Oncol Meeting Reports Lee Schwartzberg, MD, FACP, and Heather Greene, MSN, FNP, AOCNP®, reviewed optimal therapy for patients with hormone receptor–positive, HER2-negative breast cancer, as well as the management of adverse events associated with treatment. Harborside Press LLC 2020-04 2020-04-01 /pmc/articles/PMC7857322/ /pubmed/33598325 http://dx.doi.org/10.6004/jadpro.2020.11.3.12 Text en © 2020 Harborside™ http://creativecommons.org/licenses/by-nc-nd/3.0/ This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Reports
Schwartzberg, Lee
Greene, Heather
Hormone Receptor–Positive, HER2-Negative Breast Cancer: Recent Advances and Best Practices
title Hormone Receptor–Positive, HER2-Negative Breast Cancer: Recent Advances and Best Practices
title_full Hormone Receptor–Positive, HER2-Negative Breast Cancer: Recent Advances and Best Practices
title_fullStr Hormone Receptor–Positive, HER2-Negative Breast Cancer: Recent Advances and Best Practices
title_full_unstemmed Hormone Receptor–Positive, HER2-Negative Breast Cancer: Recent Advances and Best Practices
title_short Hormone Receptor–Positive, HER2-Negative Breast Cancer: Recent Advances and Best Practices
title_sort hormone receptor–positive, her2-negative breast cancer: recent advances and best practices
topic Meeting Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857322/
https://www.ncbi.nlm.nih.gov/pubmed/33598325
http://dx.doi.org/10.6004/jadpro.2020.11.3.12
work_keys_str_mv AT schwartzberglee hormonereceptorpositiveher2negativebreastcancerrecentadvancesandbestpractices
AT greeneheather hormonereceptorpositiveher2negativebreastcancerrecentadvancesandbestpractices

Ejemplares similares